IDEXX LABORATORIES INC /DE Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
IDEXX LABORATORIES INC /DE (IDXX) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $1.48 billion as of 2023-12-31, per its 10-K filed 2024-02-22.
Discontinued › Balance Sheet › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2024-02-22
- 2023-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $1.48B.
- 2022-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $608.74M.
- 2022-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $476.00M.
- 2022-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $457.01M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2023-12-31 | $1.48B 10-K · filed 2024-02-22 | |
| 2022-12-31 | $608.74M 10-K · filed 2024-02-22 | |
| 2022-09-30 | $476.00M 10-Q · filed 2022-11-01 | |
| 2022-06-30 | $457.01M 10-Q · filed 2022-11-01 | |
| 2022-03-31 | $639.80M 10-Q · filed 2022-11-01 | |
| 2021-12-31 | $689.99M 10-K · filed 2024-02-22 | |
| 2021-09-30 | $755.46M 10-Q · filed 2022-11-01 | |
| 2021-06-30 | $748.22M 10-Q · filed 2022-11-01 | |
| 2021-03-31 | $703.43M 10-Q · filed 2022-11-01 | |
| 2020-12-31 | $632.79M 10-K · filed 2024-02-22 | |
| 2020-09-30 | $441.12M 10-Q · filed 2021-11-02 | |
| 2020-06-30 | $273.40M 10-Q · filed 2021-11-02 | |
| 2020-03-31 | $108.06M 10-Q · filed 2021-11-02 | |
| 2019-12-31 | $177.82M 10-K · filed 2023-02-16 | |
| 2019-09-30 | $202.72M 10-Q · filed 2020-10-29 | |
| 2019-06-30 | $171.55M 10-Q · filed 2020-10-29 | |
| 2019-03-31 | $51.87M 10-Q · filed 2020-10-29 | |
| 2018-12-31 | -$9.23M 10-K · filed 2022-02-16 | |
| 2018-09-30 | -$1.36M 10-Q · filed 2019-10-31 | -$1.36M 10-Q · filed 2018-11-01 |
| 2018-06-30 | -$40.85M 10-Q · filed 2019-10-31 | |
| 2018-03-31 | -$48.98M 10-Q · filed 2019-10-31 | -$48.98M 10-Q · filed 2018-05-04 |
| 2018-01-01 | -$58.82M 10-Q · filed 2018-11-01 | |
| 2017-12-31 | -$53.84M 10-K · filed 2021-02-12 | |
| 2017-09-30 | -$48.39M 10-Q · filed 2017-10-31 | |
| 2017-06-30 | -$86.11M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | -$73.91M 10-Q · filed 2017-04-28 | |
| 2016-12-31 | -$108.21M 10-K · filed 2020-02-14 | |
| 2016-09-30 | $54.99M 10-Q · filed 2016-11-01 | |
| 2016-06-30 | -$8.50M 10-Q · filed 2016-08-02 | |
| 2016-03-31 | -$73.79M 10-Q · filed 2016-04-29 | |
| 2015-12-31 | -$84.00M 10-K · filed 2019-02-15 | |
| 2015-09-30 | -$38.80M 10-Q · filed 2015-10-28 | |
| 2015-06-30 | $8.55M 10-Q · filed 2015-07-30 | |
| 2015-03-31 | $34.08M 10-Q · filed 2015-04-28 | |
| 2014-12-31 | $117.59M 10-K · filed 2018-02-16 | |
| 2014-09-30 | $229.47M 10-Q · filed 2014-10-24 | |
| 2014-06-30 | $452.93M 10-Q · filed 2014-07-25 | |
| 2014-03-31 | $512.25M 10-Q · filed 2014-04-25 | |
| 2013-12-31 | $518.21M 10-K · filed 2017-02-17 | |
| 2013-09-30 | $534.89M 10-Q · filed 2013-10-22 | |
| 2013-06-30 | $549.59M 10-Q · filed 2013-07-23 | |
| 2013-03-31 | $631.29M 10-Q · filed 2013-04-23 | |
| 2012-12-31 | $636.26M 10-K · filed 2016-02-17 | |
| 2012-09-30 | $617.53M 10-Q · filed 2012-10-19 | |
| 2012-06-30 | $589.94M 10-Q · filed 2012-07-20 | |
| 2012-03-31 | $566.88M 10-Q · filed 2012-04-20 | |
| 2011-12-31 | $539.59M 10-K · filed 2015-02-17 | |
| 2011-09-30 | $585.97M 10-Q · filed 2011-10-21 | |
| 2011-06-30 | $608.81M 10-Q · filed 2011-07-22 | |
| 2011-03-31 | $596.91M 10-Q · filed 2011-04-21 | |
| 2010-12-31 | $574.28M 10-K · filed 2014-02-18 | |
| 2010-09-30 | $546.65M 10-Q · filed 2010-10-22 | |
| 2010-06-30 | $524.28M 10-Q · filed 2010-07-23 | |
| 2009-12-31 | $514.58M 10-K · filed 2013-02-19 | |
| 2008-12-31 | $438.19M 10-K · filed 2012-02-17 | |
| 2007-12-31 | $438.32M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |